Panacea Phytoextracts Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 16-11-2024
- Paid Up Capital ₹ 0.20 M
as on 16-11-2024
- Company Age 5 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 16-11-2024
- Revenue 50.41%
(FY 2023)
- Profit 155.52%
(FY 2023)
- Ebitda 81.31%
(FY 2023)
- Net Worth 132.08%
(FY 2023)
- Total Assets 9.06%
(FY 2023)
About Panacea Phytoextracts
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.50 Cr.
Poonam Gupta and Gaurav Kaushik serve as directors at the Company.
- CIN/LLPIN
U36990GJ2019PTC107900
- Company No.
107900
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Apr 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Panacea Phytoextracts Private Limited offer?
Panacea Phytoextracts Private Limited offers a wide range of products and services, including Ayurvedic & Herbal Extracts, Floral Extract, Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Spices Extracts, Herbs,Sticks and Roots, Plant Extracts, Fruit Extracts, Herbal Extracts.
Who are the key members and board of directors at Panacea Phytoextracts?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Gupta  | Director | 30-Apr-2019 | Current |
| Gaurav Kaushik | Director | 30-Apr-2019 | Current |
Financial Performance and Corporate Structure Insights of Panacea Phytoextracts.
Panacea Phytoextracts Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 50.41% increase. The company also saw a substantial improvement in profitability, with a 155.52% increase in profit. The company's net worth Soared by an impressive increase of 132.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panacea Phytoextracts?
In 2023, Panacea Phytoextracts had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Meteoric Biopharmaceuticals Private LimitedActive 18 years 8 monthsPoonam Gupta and Gaurav Kaushik are mutual person
Meteoric Cosmeceutiicals Private LimitedActive 2 years 5 monthsPoonam Gupta and Gaurav Kaushik are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 01 Mar 2024 | ₹1.50 Cr | Open |
How Many Employees Work at Panacea Phytoextracts?
Unlock and access historical data on people associated with Panacea Phytoextracts, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panacea Phytoextracts, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panacea Phytoextracts's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
